The hypertensive patient

References

• Drizd T, Dannenberg AL, Engel A. Blood pressure levels in persons 18–74 years of age in 1976–80, and trends in blood pressure from 1960–1980 in the United States. Hyattsville, MD: US Dept of Health and Human Services, 1986; DHHS publication No. (PHS) 86–1684 (Vital Health Statistics Series, No. 11)
   Google Scholar
• Messerli FH, Sundgaard-Riise K, Ventura HO, et al. Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 1983: 2: 983–6
   PubMed Web of Science ®Google Scholar
• Probstfield JL, Applegate WB, Borhani NO, et al. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. Clin Exp Hypertens [A] 1989: 11: 973–89
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991: 265: 3255–64
   PubMed Web of Science ®Google Scholar
• Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985: 1: 1349–54
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and prior cardiovascular disease: further analysis of side effects. Circulation 1972: 45: 991–1004
   PubMed Web of Science ®Google Scholar
• Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979: 242: 2562–71
   PubMed Web of Science ®Google Scholar
• Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race-sex and age. JAMA 1979: 242: 2572–7
   PubMed Web of Science ®Google Scholar
• Amery A, Birkenhager W, Brixko R, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986: 2: 589–92
   PubMed Web of Science ®Google Scholar
• National Heart Foundation of Australia. The Australian Therapeutic Trial in Mild Hypertension: report by the management committee. Lancet 1980: 1: 1261–7
   PubMed Web of Science ®Google Scholar
• Applegate WB. Hypertension in elderly patients. Ann Intern Med 1989: 110: 901–15
   PubMed Web of Science ®Google Scholar
• MacMahon SW, Cutler JA, Furbetg CD, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986: 29(3 Suppl 1): 99–118
   PubMed Web of Science ®Google Scholar
• Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987: 1: 581–4
   PubMed Web of Science ®Google Scholar
• Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991: 114: 345–52
   PubMed Web of Science ®Google Scholar
• Samuelsson O, Wilhelmsen L, Andersson OK, et al. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension: results from the primary prevention trial in Goteburg, Sweden. JAMA 1987: 258: 1768–76
   PubMed Web of Science ®Google Scholar
• 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988: 148: 1023–38
   PubMed Web of Science ®Google Scholar
• Dzau VJ. Evolution of the clinical management of hypertension. Am J Med 1987: 82: 36–43
   PubMed Web of Science ®Google Scholar
• Andersen GS. Atenolol versus bendroflu-methiazide in middle-aged and elderly hypertensives. Acta Med Scand 1985: 218: 165–72
   PubMedGoogle Scholar
• Wikstrand J, Westergren G, Berglund G, et al. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years: report from a double-blind international multicenter study. JAMA 1986: 255: 1304–10
   PubMed Web of Science ®Google Scholar
• Buell JC, Eliot RS, Plachetka JR, et al. Hemodynamic effects of labetolol in young and older adult hypertensives. J Clin Pharmacol 1988: 28: 327–31
   PubMed Web of Science ®Google Scholar
• Pool PE, Massie BM, Venkataraman K, et al. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial. Am J Cardiol 1986: 57: 212–7
   PubMed Web of Science ®Google Scholar
• Applegate WB, Miller ST. Choice of anti-hypertensive medication regimen. Clin Geriatr Med 1989: 5: 803–11
   PubMedGoogle Scholar
• Materson BJ, Cushman WC, Goldstein G, et al. Treatment of hypertension in the elderly. I. Blood pressure and clinical changes: results of a Department of Veterans Affairs cooperative study. Hypertension 1990: 15: 348–60
   PubMed Web of Science ®Google Scholar
• Goldstein G, Materson BJ, Cushman WC, et al. Treatment of hypertension in the elderly. II. Cognitive and behavioral function: results of a Department of Veterans Affairs cooperative study. Hypertension 1990: 15: 361–9
   PubMed Web of Science ®Google Scholar
• Applegate WB, Phillips HL, Schnaper H, et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991: 151: 1817–23
   PubMed Web of Science ®Google Scholar
• Quinn BP, Applegate WB, Roberts K, et al. Knowledge and use of medications in a group of elderly individuals. J Tenn Med Assoc 1983: 76: 647–9
   PubMedGoogle Scholar